Adverse Events of Ibrutinib in Chronic Lymphocytic Leukemia

1 Views
administrator
administrator
07/08/23

In this segment, Jennifer Brown, MD, and Richard Furman, MD, review adverse events associated with ibrutinib therapy in the treatment of chronic lymphocytic leukemia (CLL).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next